Quoc Le-Nguyen
2021
In 2021, Quoc Le-Nguyen earned a total compensation of $1.9M as Chief Technical Operations Officer and Head of Quality at 89bio, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,160 |
|---|---|
| Option Awards | $1,123,828 |
| Salary | $410,000 |
| Stock Awards | $230,100 |
| Other | $6,963 |
| Total | $1,925,051 |
Le-Nguyen received $1.1M in option awards, accounting for 58% of the total pay in 2021.
Le-Nguyen also received $154.2K in non-equity incentive plan, $410K in salary, $230.1K in stock awards and $7K in other compensation.
Rankings
In 2021, Quoc Le-Nguyen's compensation ranked 6,179th out of 12,415 executives tracked by ExecPay. In other words, Le-Nguyen earned more than 50.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,179 out of 12,415 | 50th |
Division Manufacturing | 2,618 out of 5,505 | 52nd |
Major group Chemicals And Allied Products | 1,141 out of 2,375 | 52nd |
Industry group Drugs | 1,015 out of 2,096 | 52nd |
Industry Pharmaceutical Preparations | 734 out of 1,546 | 53rd |
Source: SEC filing on April 14, 2022.
Le-Nguyen's colleagues
We found two more compensation records of executives who worked with Quoc Le-Nguyen at 89bio in 2021.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020